Skip to main content
. 2018 Mar 25;84(6):1198–1205. doi: 10.1111/bcp.13542

Table 1.

Characteristics of study population

Characteristics Cases (n = 7039) Controls (n = 70390) Unadjusted OR P value*
Gestational age at index date (weeks); mean (SD) **
Socio‐demographics status ( n , %) a 14.3 ± 2.8 14.3 ± 2.8 0.9904
Maternal age (years), mean (SD) ** 28.9 ± 6.3 27.9 ± 5.6 <0.001
<18 (ref.) 104 (1.5) 1035 (1.5) 1.00
18–34 5415 (76.9) 59 612 (84.7) 1.10 (0.90–1.34)
>34 1520 (21.6) 9743 (13.8) 1.69 (1.59–1.80) <0.001
Urban residence (vs. rural residence) 5816 (82.6) 57 841 (82.1) 1.03 (0.97–1.10) 0.3431
Recipient of social assistance (vs. RAMQ adherent) 1765 (25.1) 17 648 (25.1) 1.00 (0.95–1.06) 0.9958
Education (≤12 years vs. >12 years) 2933 (41.7) 29 710 (42.2) 0.98 (0.93–1.03) 0.3818
Living alone (vs. couple) 1304 (18.5) 10 592 (15.1) 1.27 (1.20–1.36) <0.001
During year before until index date b ( n , %) a
Comorbidities
Depression c (yes vs. no) 1328 (18.9) 9702 (13.8) 1.42 (1.34–1.52) <0.001
Asthma c (yes vs. no) 987 (14.0) 8335 (11.8) 1.20 (1.12–1.29) <0.001
Diabetes mellitus c (yes vs. no) 128 (1.8) 1233 (1.8) 1.04 (0.87–1.24) 0.6844
Hypertension c (yes vs. no) 213 (3.0) 1779 (2.5) 1.20 (1.04–1.38) 0.0118
Thyroid disorders c (yes vs. no) 278 (4.0) 2581 (3.7) 1.08 (0.95–1.22) 0.2304
Urinary tract infection d (yes vs. no) 745 (10.6) 6838 (9.7) 1.10 (1.01–1.18) 0.0193
Respiratory tract infection d (yes vs. no) 2325 (33.0) 21 091 (30.0) 1.15 (1.09–1.21) <0.001
Sexually transmitted diseases d (yes vs. no) 259 (3.7) 2563 (3.6) 1.01 (0.89–1.15) 0.8699
Endometriosis d (yes vs. no) 72 (1.0) 441 (0.6) 1.53 (1.19–1.96) <0.001
Bacterial vaginosis d (yes vs. no) 578 (8.2) 5424 (7.7) 1.07 (0.98–1.17) 0.1303
Epilepsy c (yes vs. no) 142 (2.0) 881 (1.3) 1.60 (1.34–1.91) <0.001
Uterine malformations d (yes vs. no) 5 (<0.1) 29 (<0.1) 1.70 (0.67–4.27) 0.2546
In the year before the first day of gestation
Health care utilization ( n , %) a
Inpatient or emergency visit 2530 (35.9) 29 030 (32.6) 1.15 (1.09–1.20) <0.001
No. of visits to physicians
0 (ref.) 1900 (27.0) 20 976 (29.8) 1.00
1–2 1404 (20.0) 15 556 (22.1) 0.99 (0.93–1.06)
≥3 3735 (53.0) 33 858 (48.1) 1.20 (1.15–1.26) <0.001
Medications
Penicillins use (yes vs. no) 1369 (19.5) 12 824 (18.2) 1.07 (1.02–1.14) 0.0110
*** TMP‐SMX use (yes vs. no) 89 (1.3) 763 (1.1) 1.16 (0.94–1.44) 0.1665
Other drugs excluding anti‐infective
0 (ref.) 2179 (31.0) 24 084 (34.2) 1.00
1–2 1597 (22.7) 16 134 (22.9) 1.09 (1.02–1.16)
≥3 3263 (46.3) 30 172 (42.9) 1.18 (1.12–1.25) <0.001
Obstetrics complications
History of prior SA **** (yes vs. no) 140 (2.0) 746 (1.1) 1.85 (1.55–2.21) <0.001
History of prior abortion (yes vs. no) 431 (6.1) 3128 (4.4) 1.38 (1.25–1.1) <0.001
During pregnancy ( n , %) a
*** TMP‐SMX use e , f (yes vs. no) 25 (0.4) 77 (0.1) 3.11 (2.01–4.81) <0.0001
Penicillins f , g (yes vs. no) 427 (6.1) 4777 (6.8) 0.89 (0.81–0.99) <0.0001
*

P‐value calculated to compared cases of SA and controls using Pearson χ2 test for categorical variables and a t‐test for continuous variables.

**

SD, standard deviation;

***

TMP‐SMX, trimethoprim–sulfamethoxazole;

****

SA, spontaneous abortion.

a

Unless otherwise stated.

b

Index date = date of spontaneous abortion for cases and corresponding date for matched controls.

c

Based on ICD‐9 or ICD‐10 codes or prescription filled for chronic diseases (hypertension, diabetes, asthma, depression, etc.).

d

Based on ICD‐9 or ICD‐10 codes for urinary tract infections, respiratory tract infections, bacterial vaginosis, endometriosis, sexually transmitted disease and uterine malformations.

e

Include pregnancies having filled at least one prescription for trimethoprim–sulfamethoxazole only between the start of pregnancy and the index date.

f

No exposure to antibiotics.

g

Include pregnancies having filled at least one prescription for penicillins only between the start of pregnancy and the index date.